Allergic bronchopulmonary aspergillosis is an immunological response to the fungus Aspergillus, leading to airway inflammation and obstruction. It is clinically significant as it can cause chronic respiratory issues and may lead to irreversible lung damage if untreated. The ICD-10 Code B44.81 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate management of this condition.
What is ICD-10 Code B44.81 for Allergic bronchopulmonary aspergillosis?
ICD-10 Code B44.81 represents Allergic bronchopulmonary aspergillosis, a hypersensitivity reaction to Aspergillus species. This condition is often associated with asthma and cystic fibrosis. The code should be used in clinical documentation and billing when a patient presents with symptoms indicative of this allergic response, ensuring proper treatment and management.
ICD-10 Code B44.81 – Clinical Definition and Explanation of Allergic bronchopulmonary aspergillosis
Allergic bronchopulmonary aspergillosis is caused by an exaggerated immune response to inhaled Aspergillus spores, leading to airway inflammation and obstruction. It requires medical attention to prevent chronic lung damage and exacerbation of asthma symptoms.
Key Clinical Features:
- Recurrent wheezing and coughing
- Shortness of breath
- Fever and malaise
- Eosinophilia and elevated IgE levels
ICD-10 Code B44.81 for Allergic bronchopulmonary aspergillosis – SOAP Notes & Clinical Use
ICD-10 Code B44.81 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It is relevant in both acute and chronic care settings, ensuring comprehensive care and accurate billing.
What Does ICD-10 Code B44.81 for Allergic bronchopulmonary aspergillosis Mean in SOAP Notes?
In SOAP notes, ICD-10 Code B44.81 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of allergic bronchopulmonary aspergillosis. This ensures continuity of care, supports billing, and meets EHR documentation standards.
Treatment Options for ICD-10 Code B44.81 – Allergic bronchopulmonary aspergillosis
Allergic bronchopulmonary aspergillosis may require hospitalization for severe cases. Treatment focuses on managing symptoms and preventing complications.
Antibiotic Therapy:
- Oral corticosteroids (e.g., prednisone) for inflammation
- Itraconazole as a first-line antifungal
- Alternative: Voriconazole if resistant
Supportive Care:
- Bronchodilators for airway obstruction
- Oxygen therapy if hypoxemic
- Monitoring for asthma exacerbations
Infection Control:
- Educate on avoiding exposure to mold
- Implement environmental controls to reduce allergens
- Consider isolation during outbreaks of fungal infections
How to Document Symptoms of Allergic bronchopulmonary aspergillosis (ICD-10 B44.81) in SOAP Notes
Subjective:
- Patient reports increased wheezing and coughing
- History of asthma exacerbations
- Known exposure to moldy environments
- Symptoms worsening with seasonal changes
Objective:
- Wheezing noted on auscultation
- Respiratory rate: 22 breaths/min
- Oxygen saturation: 92% on room air
- Peak flow measurement: 60% of personal best
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Allergic bronchopulmonary aspergillosis (ICD-10 Code B44.81)
Assessment:
- Diagnosis: Allergic bronchopulmonary aspergillosis, moderate severity
- ICD-10 Code: B44.81
- Triggers: Mold exposure, asthma history
- Consideration of underlying asthma exacerbation
Plan:
- Initiate oral corticosteroids for inflammation
- Prescribe bronchodilators as needed
- Educate on allergen avoidance strategies
- Schedule follow-up in 4 weeks for reassessment
Treatment & Plan Section for ICD-10 Code B44.81 – Allergic bronchopulmonary aspergillosis
- First-line treatment includes inhaled corticosteroids and bronchodilators
- Non-pharmacologic strategies include allergen control and environmental modifications
- Monitoring through peak flow tracking and regular follow-ups
- Patient education on recognizing exacerbation symptoms and action plans
Using ICD-10 Code B44.81 for Allergic bronchopulmonary aspergillosis in Billing & SOAP Note Compliance
- Select appropriate subcodes based on severity and complications
- Document symptoms clearly under Subjective (S) and Objective (O) sections
- Ensure treatment plans align with clinical guidelines for justified billing
- List CPT codes commonly billed with ICD-10 Code B44.81
Related ICD-10 Codes Often Used with Allergic bronchopulmonary aspergillosis
- B44.0 – Allergic Aspergillus sinusitis
ICD-10 Code B44.81 in Medical Billing and Insurance for Allergic bronchopulmonary aspergillosis
ICD-10 Code B44.81 is crucial for billing in hospital, ER, or infectious disease care settings.
Billing Notes:
- Document all relevant symptoms and history to support the diagnosis
- Use the code in appropriate clinical settings to ensure accurate billing
- Include key chart elements such as treatment plans and follow-up recommendations
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, level 3 |
| 94640 | Pressurized or non-pressurized inhalation treatment |
| 36415 | Collection of venous blood by venipuncture |
| 95004 | Allergy testing, skin, intradermal |
Frequently Asked Questions
Common Questions About Using ICD-10 Code B44.81 for Allergic bronchopulmonary aspergillosis
What are the common symptoms of allergic bronchopulmonary aspergillosis?
Common symptoms include wheezing, coughing, shortness of breath, and fever. Patients may also experience increased mucus production and fatigue, particularly during asthma exacerbations.
Is allergic bronchopulmonary aspergillosis contagious?
No, allergic bronchopulmonary aspergillosis is not contagious. It is an allergic reaction to a fungus and does not spread from person to person.
What triggers allergic bronchopulmonary aspergillosis?
Common triggers include exposure to moldy environments, such as damp basements or decaying vegetation. Individuals with asthma or cystic fibrosis are at higher risk.
How is allergic bronchopulmonary aspergillosis treated?
Treatment typically involves corticosteroids to reduce inflammation, antifungal medications, and bronchodilators to relieve symptoms. Avoiding allergens is also crucial for management.
